查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496006

全球骨水泥市場：2024-2029 年預測

Global Bone Cement Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 160 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

骨水泥市場預計在預測期內將以 5.67% 的複合年成長率成長，從 2022 年的 17.8 億美元增至 2029 年的 26.19 億美元。

骨水泥是指將聚甲基丙烯酸甲酯（PMMA）、磷酸鈣、玻璃聚鏈烯酸酯等粉末與液態單體混合而成的合成生物材料。這種水泥具有超強的黏合性能，可應用於髖關節、膝關節和關節關節重建等整形外科手術。自癒特性和作為人工關節的功能正在推動醫療領域對骨水泥的需求。

災難性傷害、事故、整形外科手術生產者數量的增加，加上人口老化的加劇，正在為骨水泥市場創造進一步的成長機會。例如，根據美國勞工統計局提供的資料，2019年美國發生的致命工傷事故為5,333起，比2015年發生的4,836起大幅增加10.3%。

隨著此類死亡人數的增加，骨水泥在治療所有骨骼相關損傷中的使用範圍也在擴大，從而推動了預測期內骨水泥市場的需求和成長。市場區隔分為聚甲基丙烯酸甲酯、磷酸鈣、玻璃聚鏈烯酸酯。在骨水泥市場的預測期內，聚甲基丙烯酸甲酯領域預計將出現相對較高的成長率。

聚甲基丙烯酸甲酯機械強度高、毒性低、自硬化性能好，非常適合人工關節的固定。因此，PMMA骨水泥可作為骨骼和植入之間的空間填充物，改善植入的固定。聚丙烯酸甲酯骨水泥的高性能，加上其成本效益和高耐用性，預計將推動未來人工關節手術的需求，從而帶動預測期內同一細分市場的成長以及整體市場的成長。你。

市場促進因素：

  • 整形外科手術數量的快速增加正在推動骨水泥市場的需求。

骨水泥在整形外科手術中具有很高的適用性，用人造骨取代受損的骨部分，並使用骨水泥將人造骨固定指定。由於關節和骨骼疼痛、骨關節炎和交通事故的增加，尤其是老年人的整形外科手術數量每年都在顯著增加。例如，根據美國整形外科學會的年度報告，2021年美國進行了240萬例膝關節和關節重建，2021年美國總共置換術。比，增加了18.3%。

此外，根據澳洲整形外科協會國家關節置換手術登記處2022年年度報告，2021年澳洲報告的關節重建總數為185萬例，其中膝關節關節重建手術佔最大佔有率，為68,466例，其次是髖關節置換手術。置換術為 52,787 例。與2020年關節關節重建手術總數相比，2021年關節關節重建手術的整體成長率為7.6%。

隨著整形外科手術數量的增加，作為骨間隙填充材的骨水泥的需求和消耗預計也會增加，這為預測期內骨水泥市場的成長帶來了積極的前景。然而，骨水泥製備的巨大成本加上植入併發症將阻礙預測期內全球水泥市場的成長。

  • 關節和骨損傷發生率的增加可能會推動骨水泥市場的發展。

骨水泥市場是由經常需要整形外科干預的運動傷害的增加所推動的。骨水泥，也稱為聚甲基丙烯酸甲酯，用於關節重建手術中以將植入固定到骨頭上。全世界擴大參與體育運動和身體活動，導致與運動相關的傷害增加，特別是那些影響骨骼和關節的傷害。

骨水泥技術的進步，例如用於預防感染疾病和改善生物相容性的抗生素水泥，使其成為各種整形外科應用的首選。隨著人口老化和人們越來越重視保持積極的生活方式，退化性關節疾病和運動相關損傷的盛行率增加，從而增加了對整形外科手術的需求。

使用骨水泥的整形外科手術來支持復健並允許個人恢復活動能力和功能。受運動傷害影響，骨水泥市場預計將繼續擴大。

市場限制因素：

  • 高成本和嚴格的臨床資料要求可能會限制市場成長。

骨水泥開發是一個成本高且耗時的過程，需要大量的研發投資。 FDA 對外科整形外科水泥的嚴格核准程序推遲了新產品的發布。 FDA 正在要求更多有關安全性和有效性的臨床資料，這將需要進一步的研發投資。儘管有先進的水泥，但仍尋求具有必要臨床資料的具有成本效益的選擇，這影響了市場的生存。骨釘和整形外科釘等替代品也阻礙了先進骨水泥的普及。

主要進展

  • 2022 年 8 月 - Graftys 與 Arthrex 續簽了先進合成骨移植材料的多年供應協議。該協議提供了利用尖端骨科技術的多個新商機。 Graftys是一家創新主導的醫療技術公司，從事合成骨生物材料的開發和製造。該公司的目標是成為骨生醫材料設計、製造和分銷領域的領導企業，其產品組合基於臨床證據以及與歐洲領先學術研究機構的合作。
  • 2022 年 6 月 - 馬來西亞 KPower Bhd 透過其子公司 Granulab (M) Sdn Bhd 推出了 Prosteomax，該國首款獲得清真認證的合成骨水泥。磷酸鈣水泥已獲得七個國家的CE認證和馬來西亞伊斯蘭發展局（Jakim）的清真認證。它還在馬來西亞醫療設備管理局註冊用於整形外科、顱骨、牙科和顎顏面應用。 Granulab 也生產 GranuMas，這是一種顆粒狀合成骨移植物，在馬來西亞是清真產品。該公司正在與衛生福利部洽談成為馬來西亞的醫院營運公司。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球骨水泥市場：依類型

  • 介紹
  • 聚甲基丙烯酸甲酯
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 磷酸鈣
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 玻璃聚鏈烯酸酯
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章全球骨水泥市場：依黏度分類

  • 介紹
  • 低黏度
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 中等黏度
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 高黏度
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章全球骨水泥市場：依抗生素類型

  • 介紹
  • 慶大霉素
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 妥布黴素
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • Cefuroxime
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章全球骨水泥市場：依應用分類

  • 介紹
  • 人工關節重建
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 椎體成形術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 椎體成形術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第9章全球骨水泥市場：依最終用戶分類

  • 介紹
  • 醫院/診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 門診手術中心
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第10章全球骨水泥市場：按地區

  • 介紹
  • 北美洲
    • 按類型
    • 按黏度
    • 依抗生素類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按類型
    • 按黏度
    • 依抗生素類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按類型
    • 按黏度
    • 依抗生素類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按類型
    • 按黏度
    • 依抗生素類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按類型
    • 按黏度
    • 依抗生素類型
    • 按用途
    • 按最終用戶
    • 按國家/地區

第11章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第12章 公司簡介

  • DePuy Synthesis（Part of Johnson & Johnson）
  • Stryker
  • Zimmer Biomet
  • Tecres SpA
  • Synimed Synergie Ingenierie Medicale SARL
  • Olympus Corporation
  • Heraeus holdings
  • Teknimed
  • Exactech Inc.
  • DJO, LLC
簡介目錄
Product Code: KSI061611894

The global bone cement market is expected to grow at a CAGR of 5.67% over the forecast period to reach US$2.619 billion by 2029 from US$1.780 billion in 2022.

Bone cement refers to a synthetic biomaterial obtained from mixing polymethyl methacrylate (PMMA), calcium phosphate, or glass polyalkenoate powder with a liquid monomer. The cement has a super gluing feature owing to which it has high applicability in orthopedical surgical procedures such as hip, knee, and joint replacement. The self-healing nature and the ability to work as artificial joints are what drives the demand for bone cement in the medical field.

The growing prevalence of fatal injuries, accidents, and orthopedical surgical producers, coupled with the rising old age population, has provided more growth opportunities to the global bone cement market. For instance, according to the data provided by the US Bureau of Labor Statistics, in 2019, the number of fatal work injuries that occurred in the US stood at 5,333, which showed a significant increase of 10.3% in comparison to the 4,836 injuries that occurred in 2015.

With such an increase in fatal injuries, the scope of bone cement usage for the treatment of any bone-related injury also increases, thereby boosting the market demand and growth of the global bone cement market during the forecast period. The global bone cement market is segmented into polymethyl methacrylate, calcium phosphate, and glass polyalkenoate. The polymethyl methacrylate segment is expected to grow at a relatively higher rate during the forecast period of the global bone cement market.

Polymethyl Methacrylate has rich mechanical strength, minimal toxicity, and provides improved self-curing properties owing to which it has high applicability during joint prostheses fixation. Hence, acting as a space filler between the bone and the implant, PMMA bone cement improves the fixation of the implant. The high-performance features of polymethyl acrylate bone cement, coupled with its cost-effectiveness and high durability, are expected to increase its demand for joint prostheses surgeries in the future, thereby boosting its segment growth as well as the overall global bone cement market growth during the forecast period.

Market Drivers:

  • The rapid increase in the number of orthopedic surgeries is driving the market demand for bone cement.

Bone cement has high applicability in orthopedical surgical procedures where the damaged bone part is replaced with a prosthesis, and to hold the prosthesis in its place, bone cement is used. The number of orthopedical surgical procedures has shown a significant increase over the years owing to the growing number of joint & bone pain in people, especially in old age, coupled with growing cases of osteoarthritis and road accidents. For instance, according to the annual report by the American Academy of Orthopedic Surgeons, in 2021, the number of knee and hip bone replacement surgeries stood at 2.4 million in the US, which showed an increase of 18.3% in comparison to the number of surgical procedures conducted in 2020.

Furthermore, according to the 2022 annual report of the Australia Orthopaedic Association National Joint Replacement Surgery Registry, in 2021, the total number of joint replacement surgeries reported in 2021 Australia stood at 1.85 million, of which knee replacement held the largest share of 68,466, followed by hips replacement with 52,787. The overall increase in joint replacement surgeries in 2021 was 7.6% in comparison to 2020's joint replacement surgical volume.

With such an increase in the number of orthopedic surgical procedures, the demand and consumption of bone cement to act as a gap filler in bones are also anticipated to increase, thereby providing a positive outlook for the global bone cement market growth during the forecast period. However, the extensive cost incurred in preparing bone cement coupled with implant complications is projected to hamper the global cement market growth during the forecast period.

  • Increasing incidence of joints and bone injuries would propel the bone cement market.

The bone cement market is driven by the increasing number of sports injuries, which often require orthopedic interventions. Bone cement, also known as polymethylmethacrylate, is used in joint replacement procedures to anchor implants to the bone. The global increase in sports participation and physical activities has led to an increase in sports-related injuries, particularly those affecting bones and joints.

Advancements in bone cement technology, such as antibiotic-loaded cement to prevent infections or improved biocompatibility, make it a preferred choice in various orthopedic applications. The aging population and increased emphasis on maintaining an active lifestyle result in a higher prevalence of degenerative joint conditions and sports-related injuries, driving the demand for orthopedic procedures.

Orthopedic procedures involving bone cement can support rehabilitation, allowing individuals to regain mobility and function. The global bone cement market expansion is expected to continue due to the impact of sports injuries.

Market Restraints:

  • High expenses and stringent clinical data requirements could restrain the market growth.

The development of bone cement is a costly and time-consuming process that requires significant R&D investments. The FDA's stringent approval process for surgical orthopedic cement delays new product releases. The FDA demands more clinical data for safety and efficacy, resulting in additional R&D investments. Despite advanced cements, there is still a need for cost-effective options with required clinical data, affecting market survival. Alternatives like bone staples and orthopedic pins also hinder the uptake of advanced bone cement.

Key Developments:

  • August 2022- Graftys renewed its multi-year supply agreement with Arthrex for advanced synthetic bone graft materials. The agreement provided multiple new business opportunities using state-of-the-art orthobiologic technology. Graftys, an innovation-driven medtech company, is committed to the development and manufacturing of synthetic bone biomaterials. The company aims to become a major player in the design, manufacturing, and distribution of bone biomaterials, with a portfolio built on clinical evidence and partnerships with leading academic research institutions in Europe.
  • June 2022- Malaysia's KPower Bhd introduced Prosteomax, the country's first halal-certified synthetic bone cement, through its subsidiary Granulab (M) Sdn Bhd. The calcium phosphate-based cement received CE certification in seven countries and halal certification from the Islamic Development Department Malaysia (Jakim). It is registered with the Malaysian Medical Device Authority for orthopaedics, cranial, dental, and maxillofacial applications. Granulab also produces granular synthetic bone grafts, GranuMas, a halal product in Malaysia. The company is in talks with the Health Ministry to become a hospital operator in Malaysia.

Market Segmentation:

By Type

  • Polymethyl Methacrylate
  • Calcium Phosphate
  • Glass Polyalkenoate

By Viscosity

  • Low
  • Medium
  • High

By Antibiotics Type

  • Gentamicin
  • Tobramycin
  • Cefuroxime

By Application

  • Arthroplasty
  • Kyphoplasty
  • Vertebroplasty
  • Others

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Center

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • United Arab Emirates
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BONE CEMENT MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Polymethyl Methacrylate
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Calcium Phosphate
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Glass Polyalkenoate
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. GLOBAL BONE CEMENT MARKET BY VISCOSITY

  • 6.1. Introduction
  • 6.2. Low
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Medium
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. High
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL BONE CEMENT MARKET BY ANTIBIOTICS TYPE

  • 7.1. Introduction
  • 7.2. Gentamicin
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Tobramycin
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Cefuroxime
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL BONE CEMENT MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Arthroplasty
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Kyphoplasty
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Vertebroplasty
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness
  • 8.5. Others
    • 8.5.1. Market Opportunities and Trends
    • 8.5.2. Growth Prospects
    • 8.5.3. Geographic Lucrativeness

9. GLOBAL BONE CEMENT MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
    • 9.2.1. Market Opportunities and Trends
    • 9.2.2. Growth Prospects
    • 9.2.3. Geographic Lucrativeness
  • 9.3. Ambulatory Surgical Center
    • 9.3.1. Market Opportunities and Trends
    • 9.3.2. Growth Prospects
    • 9.3.3. Geographic Lucrativeness

10. GLOBAL BONE CEMENT MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Type
    • 10.2.2. By Viscosity
    • 10.2.3. By Antibiotics Type
    • 10.2.4. By Application
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. USA
        • 10.2.6.1.1. Market Opportunities and Trends
        • 10.2.6.1.2. Growth Prospects
      • 10.2.6.2. Canada
        • 10.2.6.2.1. Market Opportunities and Trends
        • 10.2.6.2.2. Growth Prospects
      • 10.2.6.3. Mexico
        • 10.2.6.3.1. Market Opportunities and Trends
        • 10.2.6.3.2. Growth Prospects
  • 10.3. South America
    • 10.3.1. By Type
    • 10.3.2. By Viscosity
    • 10.3.3. By Antibiotics Type
    • 10.3.4. By Application
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
        • 10.3.6.1.1. Market Opportunities and Trends
        • 10.3.6.1.2. Growth Prospects
      • 10.3.6.2. Argentina
        • 10.3.6.2.1. Market Opportunities and Trends
        • 10.3.6.2.2. Growth Prospects
      • 10.3.6.3. Others
        • 10.3.6.3.1. Market Opportunities and Trends
        • 10.3.6.3.2. Growth Prospects
  • 10.4. Europe
    • 10.4.1. By Type
    • 10.4.2. By Viscosity
    • 10.4.3. By Antibiotics Type
    • 10.4.4. By Application
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. Germany
        • 10.4.6.1.1. Market Opportunities and Trends
        • 10.4.6.1.2. Growth Prospects
      • 10.4.6.2. France
        • 10.4.6.2.1. Market Opportunities and Trends
        • 10.4.6.2.2. Growth Prospects
      • 10.4.6.3. United Kingdom
        • 10.4.6.3.1. Market Opportunities and Trends
        • 10.4.6.3.2. Growth Prospects
      • 10.4.6.4. Italy
        • 10.4.6.4.1. Market Opportunities and Trends
        • 10.4.6.4.2. Growth Prospects
      • 10.4.6.5. Spain
        • 10.4.6.5.1. Market Opportunities and Trends
        • 10.4.6.5.2. Growth Prospects
      • 10.4.6.6. Others
        • 10.4.6.6.1. Market Opportunities and Trends
        • 10.4.6.6.2. Growth Prospects
  • 10.5. Middle East and Africa
    • 10.5.1. By Type
    • 10.5.2. By Viscosity
    • 10.5.3. By Antibiotics Type
    • 10.5.4. By Application
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
        • 10.5.6.1.1. Market Opportunities and Trends
        • 10.5.6.1.2. Growth Prospects
      • 10.5.6.2. Israel
        • 10.5.6.2.1. Market Opportunities and Trends
        • 10.5.6.2.2. Growth Prospects
      • 10.5.6.3. United Arab Emirates
        • 10.5.6.3.1. Market Opportunities and Trends
        • 10.5.6.3.2. Growth Prospects
        • 10.5.6.3.3.
      • 10.5.6.4. Others
        • 10.5.6.4.1. Market Opportunities and Trends
        • 10.5.6.4.2. Growth Prospects
  • 10.6. Asia Pacific
    • 10.6.1. By Type
    • 10.6.2. By Viscosity
    • 10.6.3. By Antibiotics Type
    • 10.6.4. By Application
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. China
        • 10.6.6.1.1. Market Opportunities and Trends
        • 10.6.6.1.2. Growth Prospects
      • 10.6.6.2. Japan
        • 10.6.6.2.1. Market Opportunities and Trends
        • 10.6.6.2.2. Growth Prospects
      • 10.6.6.3. South Korea
        • 10.6.6.3.1. Market Opportunities and Trends
        • 10.6.6.3.2. Growth Prospects
      • 10.6.6.4. India
        • 10.6.6.4.1. Market Opportunities and Trends
        • 10.6.6.4.2. Growth Prospects
      • 10.6.6.5. Australia
        • 10.6.6.5.1. Market Opportunities and Trends
        • 10.6.6.5.2. Growth Prospects
      • 10.6.6.6. Indonesia
        • 10.6.6.6.1. Market Opportunities and Trends
        • 10.6.6.6.2. Growth Prospects
      • 10.6.6.7. Thailand
        • 10.6.6.7.1. Market Opportunities and Trends
        • 10.6.6.7.2. Growth Prospects
      • 10.6.6.8. Taiwan
        • 10.6.6.8.1. Market Opportunities and Trends
        • 10.6.6.8.2. Growth Prospects
      • 10.6.6.9. Others
        • 10.6.6.9.1. Market Opportunities and Trends
        • 10.6.6.9.2. Growth Prospects

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. DePuy Synthesis (Part of Johnson & Johnson)
  • 12.2. Stryker
  • 12.3. Zimmer Biomet
  • 12.4. Tecres SpA
  • 12.5. Synimed Synergie Ingenierie Medicale S.A.R.L
  • 12.6. Olympus Corporation
  • 12.7. Heraeus holdings
  • 12.8. Teknimed
  • 12.9. Exactech Inc.
  • 12.10. DJO, LLC